These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 18051209

  • 21. [Airway remodeling assessed by high-resolution computed tomography in patients with asthma: relationship to biological markers in induced sputum].
    Wu SM, Li CE, Cai RP, Zhang Q, Xu YJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Dec; 35(12):892-6. PubMed ID: 23328178
    [Abstract] [Full Text] [Related]

  • 22. [The role of lung volume measurements by plethysmography in the follow-up of asthma in children].
    Labbé G, Merlin E, Kauffman C, Fauquert JL, Héraud MC, Labbé A.
    Rev Mal Respir; 2010 Dec; 27(1):42-8. PubMed ID: 20146951
    [Abstract] [Full Text] [Related]

  • 23. Inhaled corticosteroids in children: use and effects of early treatment on asthma and lung function. Prevalence of asthma and the impact of severity in early life on later asthma in childhood.
    Devulapalli CS.
    Clin Respir J; 2008 Oct; 2(4):247-8. PubMed ID: 20298343
    [Abstract] [Full Text] [Related]

  • 24. Do current treatment protocols adequately prevent airway remodeling in children with mild intermittent asthma?
    Bibi HS, Feigenbaum D, Hessen M, Shoseyov D.
    Respir Med; 2006 Mar; 100(3):458-62. PubMed ID: 16046260
    [Abstract] [Full Text] [Related]

  • 25. True restrictive ventilatory pattern in asthma.
    Rothe T.
    J Asthma; 2010 Jun; 47(5):594-6. PubMed ID: 20536282
    [Abstract] [Full Text] [Related]

  • 26. [Relation between clinical severity of bronchial asthma and degree of airway inflammation assessed by the eosinophilic leukocyte count in induced sputum].
    Chlumský J, Pokorná H.
    Vnitr Lek; 2001 Sep; 47(9):604-8. PubMed ID: 11715664
    [Abstract] [Full Text] [Related]

  • 27. Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammation.
    Aggarwal S, Moodley YP, Thompson PJ, Misso NL.
    Clin Exp Allergy; 2010 Jan; 40(1):85-93. PubMed ID: 19895589
    [Abstract] [Full Text] [Related]

  • 28. Risk factors associated with irreversible airflow limitation in asthma.
    ten Brinke A.
    Curr Opin Allergy Clin Immunol; 2008 Feb; 8(1):63-9. PubMed ID: 18188020
    [Abstract] [Full Text] [Related]

  • 29. Reduced airway distensibility, fixed airflow limitation, and airway wall remodeling in asthma.
    Ward C, Johns DP, Bish R, Pais M, Reid DW, Ingram C, Feltis B, Walters EH.
    Am J Respir Crit Care Med; 2001 Nov 01; 164(9):1718-21. PubMed ID: 11719315
    [Abstract] [Full Text] [Related]

  • 30. Clinical significance of small airway obstruction markers in patients with asthma.
    Gonem S, Natarajan S, Desai D, Corkill S, Singapuri A, Bradding P, Gustafsson P, Costanza R, Kajekar R, Parmar H, Brightling CE, Siddiqui S.
    Clin Exp Allergy; 2014 Apr 01; 44(4):499-507. PubMed ID: 24341600
    [Abstract] [Full Text] [Related]

  • 31. Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention.
    Girodet PO, Ozier A, Bara I, Tunon de Lara JM, Marthan R, Berger P.
    Pharmacol Ther; 2011 Jun 01; 130(3):325-37. PubMed ID: 21334378
    [Abstract] [Full Text] [Related]

  • 32. The importance of airway remodelling in the natural course of asthma.
    Janson C.
    Clin Respir J; 2010 May 01; 4 Suppl 1():28-34. PubMed ID: 20500607
    [Abstract] [Full Text] [Related]

  • 33. Plasma connective tissue growth factor levels as potential biomarkers of airway obstruction in patients with asthma.
    Kato M, Fujisawa T, Hashimoto D, Kono M, Enomoto N, Nakamura Y, Inui N, Hamada E, Miyazaki O, Kurashita S, Maekawa M, Suda T.
    Ann Allergy Asthma Immunol; 2014 Sep 01; 113(3):295-300. PubMed ID: 24973271
    [Abstract] [Full Text] [Related]

  • 34. Effects of pharmacological and non-pharmacological interventions.
    Sandström T.
    Clin Respir J; 2010 May 01; 4 Suppl 1():41-8. PubMed ID: 20500609
    [Abstract] [Full Text] [Related]

  • 35. Sputum levels of transforming growth factor-beta1 in asthma: relation to clinical and computed tomography findings.
    Yamaguchi M, Niimi A, Matsumoto H, Ueda T, Takemura M, Matsuoka H, Jinnai M, Otsuka K, Oguma T, Takeda T, Ito I, Chin K, Mishima M.
    J Investig Allergol Clin Immunol; 2008 May 01; 18(3):202-6. PubMed ID: 18564632
    [Abstract] [Full Text] [Related]

  • 36. Monitoring airway remodeling in asthma.
    Larsson K.
    Clin Respir J; 2010 May 01; 4 Suppl 1():35-40. PubMed ID: 20500608
    [Abstract] [Full Text] [Related]

  • 37. Airway factor XIII associates with type 2 inflammation and airway obstruction in asthmatic patients.
    Esnault S, Kelly EA, Sorkness RL, Evans MD, Busse WW, Jarjour NN.
    J Allergy Clin Immunol; 2016 Mar 01; 137(3):767-73.e6. PubMed ID: 26525229
    [Abstract] [Full Text] [Related]

  • 38. Clinical and biological factors associated with irreversible airway obstruction in adult asthma.
    Graff S, Bricmont N, Moermans C, Henket M, Paulus V, Guissard F, Louis R, Schleich F.
    Respir Med; 2020 Dec 01; 175():106202. PubMed ID: 33202369
    [Abstract] [Full Text] [Related]

  • 39. Smoking, longer disease duration and absence of rhinosinusitis are related to fixed airway obstruction in Koreans with severe asthma: findings from the COREA study.
    Lee T, Lee YS, Bae YJ, Kim TB, Kim SO, Cho SH, Moon HB, COhort for Reality and Evolution of adult Asthma in Korea study group (COREA study group), Cho YS.
    Respir Res; 2011 Jan 03; 12(1):1. PubMed ID: 21194498
    [Abstract] [Full Text] [Related]

  • 40. Risk factors associated with irreversible airway obstruction in nonsmoking adult patients with severe asthma.
    Ciebiada M, Domagała M, Gorska-Ciebiada M, Gorski P.
    Allergy Asthma Proc; 2014 Jan 03; 35(5):72-9. PubMed ID: 25295799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.